title: Intravenous and oral ciprofloxacin in the treatment of proven pelvic inflammatory disease. A comparison with doxycycline and metronidazole.
authors.affiliation: Department of Obstetrics and Gynecology, Tampere University Central Hospital, Finland.
authors.forename: P K
authors.initials: PK
authors.lastname: Heinonen
authors.forename: K
authors.initials: K
authors.lastname: Teisala
authors.forename: R
authors.initials: R
authors.lastname: Aine
authors.forename: A
authors.initials: A
authors.lastname: Miettinen
mesh_terms: D000284:Administration, Oral; D001419:Bacteria / Q000302:isolation & purification; D002097:C-Reactive Protein / Q000032:analysis; D002939:Ciprofloxacin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D000292:Pelvic Inflammatory Disease / Q000145:classification / Q000188:drug therapy*
chemical_list: D008795:Metronidazole; D002939:Ciprofloxacin; D002097:C-Reactive Protein; D004318:Doxycycline